
The advent of tear osmolarity as a practical tool for diagnosis, determination of severity of disease and as a reliable objective measure of response to treatment is a game changer for clinicians faced daily in their offices with patients suffering from this disease. TearLab Corporation recently received a letter from the FDA … [Read more...]










